A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
Clinical trial NCT07703475 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07703475
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2027-11-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.